Dose response of airways to Methacholine shows a decreased contractility in <i>GSTCD</i>^-/- mouse lungs following LPS treatment. by Bo Liu (127343)

Required soil organic carbon content and maximum strain energy density as a function of normalized water content for clay contents of 16% and 50%. by Siul Ruiz (757454)

Projection of testing costs under different cost scenarios for medical supplies and personnel (USD). by Nelmo Jordão Manjate (16324619)

Subjects:

Summary of resources per type of test and costs for Ag-RDT tests (USD 2020). by Nelmo Jordão Manjate (16324619)

Subjects:

Unit cost per test type and per health facility for diagnosis of SARS-CoV-2 by Ag-RDT and RT-PCR. by Nelmo Jordão Manjate (16324619)

Subjects:

Average value of cost components composing the unit cost (in USD) of SARS-CoV-2 diagnosis per per device type. by Nelmo Jordão Manjate (16324619)

Subjects:

MTT assay shows that the cells exposed to periostin siRNA showed a significant decrease in IC50 among the DDP, EPI, and DTX compared with the control siRNA group (control group) (<i>P</i><0.01). by Dongyang Xu (303547)

“…<p>MTT assay shows that the cells exposed to periostin siRNA showed a significant decrease in IC50 among the DDP, EPI, and DTX compared with the control siRNA group (control group) (<i>P</i><0.01).…”

Fitting curve of rock E₅₀. by Junxia Zhou (14381598)

siRNA mediated knockdown of hZNF-134 decreased the viral transcript levels and the final viral titer output measured by p24 ELISA. by Ronald Benjamin (440573)

“…Scrambled siRNA was used as a control. 50picomoles of each siRNA were used. …”

Control group common bigram words (Top 50) before and after pandemic. by Yuxuan Cai (19226202)

Removal of specific N-glycans can alter neutralization potency and completeness. by Sabrina Lusvarghi (2329267)

“…Colors as follow: red, decrease in potency >4-fold; white, no change in IC₅₀ (ratios between 0.25- and 4-fold) and blue increase in potency (ratios <0.25-fold). …”

Increased mitochondrial mass determined by FACS analysis in control (WT) C2C12 clones exposed to Br-A23187. by Sylvie Ducreux (307645)

“…<p>A) FACS histogram of WT C2C12 cells treated for 48 h with Br-A23187 (1 µM) and loaded with Mito Tracker Green. …”

Treatment of MCMV infected neonates with dexamethasone decreases infiltration of inflammatory cells and expression of interferon stimulated genes in the CNS without increasing leve... by Kate Kosmac (386527)

A Functional 12T-Insertion Polymorphism in the <i>ATP1A1</i> Promoter Confers Decreased Susceptibility to Hypertension in a Male Sardinian Population by Victoria L. Herrera (383897)

“…The <i>ATP1A1</i> promoter containing the 12T-insertion exhibited decreased transcriptional activity in in vitro reporter-assay systems, indicating decreased α1Na,K-ATPase expression with the 12T-insertion, compared with the 12T-deletion <i>ATP1A1</i> promoter. …”

Exogenous expression of Tr/E significantly decreases mRNA expression of ISG56 in Ad/Tr-cells following polyI∶C stimulation. by Anna G. Drannik (292104)

Culture on rDLL1 decreases the number of single megakaryocytes and increases the size of megakaryocytic colonies generated by CD9^High MEPs. by Michèle Weiss-Gayet (505300)

Decreased numbers of cells positive for Ki67 and BrdU in nodules of MB allograft treated with AAV-<i>Tis21</i> viral particles. by Dario Presutti (828288)

<i>Ctsz</i>^{<i>−/−</i>} mice have higher lung burden and earlier spleen dissemination during acute infection followed by greater chronic inflammation and mortality risk.... by Rachel K. Meade (22216529)

<i>Ubr5</i>^<i>mt</i> synovium exhibits markers of increased canonical and decreased non-canonical HH signalling. by David Mellis (2833469)

The prevalence of hypertension, diabetes, metabolic syndrome, cardiovascular disease and decreased GFR according to the following age groups: 60–69, 70–79 and ≥80 years. by Regina C. R. M. Abdulkader (302450)

“…Metabolic syndrome: presence of at least three of the following criteria: a waist circumference ≥90 cm for men or ≥80 cm for women, triglycerides ≥150 mg/dL, an HDL cholesterol ≤40 mg/dL for males or ≤50 mg/dL for females, a systolic blood pressure ≥130 mm Hg or a diastolic blood pressure ≥85 mmHg and a fasting plasma glucose ≥100 mg/dL. …”